If and when it is approved, $100M valuation is not out of the question. It's safety and ease as well its effectiveness (albeit modest) can't be ignored. Also keep in mind that the system remains implanted in the trial patients, meaning by the time the ad-com panel meets, Entromedics can show additional and continual weight loss. In which case, we would see a nice spike in the stock price. remember that Arena went through a similar collapse before rebounding substantially post ad-com recommendation.
You know what they say: when you can't attack the message, attack the messenger. You haven't said one thing that disproves or doubts my position. All of you need a little sanity.
Given the CEO's experience with Lovaza (Remember that Joe Z. was the COO of Reliant Pharma and helped launched Lovaza), I think Vascepa can have a good launch. I would be surprised if it didn't. My contention is on the long term outlook of the company. Amarin has only one drug with little protection from potential competitors. I know everyone wants to point to the patent but if Amarin can develop a drug very similar to Lovaza while Lovaza is still within its patent life, what make you think that someone else can't do to Vascepa what Vascepa did to Lovaza?
The NCE would be that protection. But what are the chances of getting a full NCE? If chances are low, you short; if chances are high, you go long.
You can disagree with this but you need substantial support for that disagreement.
That's kind of the point. Effectively, Lovaza and Vascepa are the product. It just happens that Vascepa is a purer version of Lovaza. And Lovaza still has its patents. So, how is it that Amarin developed Vascepa without violating Lovaza's patent? The answer is that the patent protects the manufacturing process not the product. Meaning another company can develop another process and create a similar if not better version of Vascepa. This is why the NCE is so important. Hope this helps.
Don't disagree with anything your saying, but what is the company worth? That's what we invest in. Great product but not necessarily a great investment.
Wow - you googled me. I should be flattered. I didn't google you. I did educate myself - clearly more than you.
Just so I am clear on what you're saying, you don't think there is any other process outside of Amarin's to purify fish oil, including what GSK does with Lovaza? More importantly, other pharmas with giant R&D and legal budgets can't figure one out? Is that what you are saying?
I know you got money in Amarin, but don't let money make your brain go stupid.
What barrier do you see for GSK, Pfizer, or any large pharma with billions on its balance sheet? If Vacepa get approval for other indications and other pharmas are able to create their version of Vacepa, what competitive advantage does Vacepa have then? By the way, I have bough and sold Amarin many times.
Seriously before you open your mouth, think a little.
I actually have used Groupon and I find that you get what you pay for. To me, it's equivalent to Priceline's Name Your Own Price model; you can get a flight super cheap but there is a heavy price to pay in terms of connections, time day you flight leaves, and the fact that it is non-refundable or transferable. I think most Groupon customers go into it aware of that.
EnteroMedics VBLOC Obesity Device Fails [View article]
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Finally, a kind word :)
Amarin's Descent To $5 [View article]
The NCE would be that protection. But what are the chances of getting a full NCE? If chances are low, you short; if chances are high, you go long.
You can disagree with this but you need substantial support for that disagreement.
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Just so I am clear on what you're saying, you don't think there is any other process outside of Amarin's to purify fish oil, including what GSK does with Lovaza? More importantly, other pharmas with giant R&D and legal budgets can't figure one out? Is that what you are saying?
I know you got money in Amarin, but don't let money make your brain go stupid.
Amarin's Descent To $5 [View article]
Seriously before you open your mouth, think a little.
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Amarin's Descent To $5 [View article]
Groupon: Growth Vs. Profitability [View article]